Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine

Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine BILTHOVEN, Netherlands and BASEL, Switzerland, 29 July, 2020 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, and Celonic Group, a premium biopharmaceutical contract development and manufacturing organization (CDMO), specialized in development and production of Advanced Therapy Medicinal…

Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio

Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio Bilthoven, The Netherlands, 1 July 2020 – Bilthoven, The Netherlands based Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines, today announced the signing of a strategic partnership agreement with Dutch based…